For more questions or concerns, drop us an email at [email protected]
Growth Potential: As the company expands its product portfolio and enters new markets, affiliates get to share in the increasing profits and success
Clinical development is underway in a number of countries for the treatment of several diseases/symptoms: cerebral ischaemia, epilepsy, infantile spasms, opioid abuse, heroin-related disorders, Parkinson's disease, Rett syndrome, schizophrenia, and tuberous sclerosis
Stratified analyses by ejection fraction revealed that patients with borderline LVEF (5055%) exhibited more pronounced cardiovascular benefits, highlighting potential therapeutic overlap between HFpEF and HFmrEF
Comparing cannabis with tobacco